Villegas J C, Broadwell R D
Department of Surgery, University of Maryland School of Medicine, Baltimore 21201.
J Neurocytol. 1993 Feb;22(2):67-80. doi: 10.1007/BF01181571.
Morphological evidence of the potential for adsorptive transcytosis of protein through the mammalian blood-brain fluid barriers, first reported from this laboratory in the mouse, has been confirmed and expanded upon in rats injected intravenously or into the lateral cerebral ventricle/subarachnoid space with with exogenous lectin wheatgerm agglutinin (WGA) conjugated to horseradish peroxidase (HRP). Blood-borne WGA-HRP rapidly enters cerebral endothelia by the process of adsorptive endocytosis and labels the vascular tree throughout the CNS. At 3 h post-injection and longer, WGA-HRP occupies the perivascular clefts and labels perivascular cells and basal lamina; this suspected transendothelial transfer of the lectin conjugate from blood to brain involves specific constituents of the endothelial endomembrane system of organelles (e.g., plasmalemma, vesicles, endosomes, Golgi complex). Within 6 h, reaction product is evident in extracellular clefts beyond the perivascular basal lamina and labels endocytic vesicles, endosomes, and dense bodies within cells and processes of the neuropil. Exposure of the abluminal surface of blood-brain barrier endothelia for 1-18 h to WGA-HRP delivered into the cerebral ventricles or subarachnoid space indicates blood-brain barrier endothelia do not engage in demonstrable adsorptive endocytosis at the abluminal surface. In this preparation, no endothelial organelles comparable to those sequestering blood-borne WGA-HRP are labelled with the lectin conjugate; hence, significant adsorptive transcytosis of WGA-HRP through cerebral endothelia from brain to blood is unlikely. The demonstrable difference in membrane internalization of the luminal versus abluminal plasmalemma of blood-brain barrier endothelia suggests the blood-brain barrier is polarized regarding adsorptive endocytosis of WGA-HRP. If adsorptive transcytosis of macromolecules through the blood-brain barrier does occur, the process appears unidirectional, from blood to brain but not from brain to blood. Absence of demonstrable endocytosis at the abluminal front is an enigma in the scheme of transcytosis through the blood-brain barrier from blood to brain insofar as exocytosis and endocytosis are complementary events in the cellular secretory process. This unconventional membrane behavior associated with the abluminal plasmalemma argues against a significant transcytosis of blood-borne protein through blood-brain barrier endothelia. The potential for transcytosis of macromolecules through the blood-cerebrospinal fluid barrier of choroid plexus epithelia is not as problemmatic as that through blood-brain barrier endothelia; additional evidence is provided to suggest choroid plexus epithelia participate in adsorptive endocytosis circumferentially and adsorptive transcytosis of WGA-HRP bidirectionally between the blood and cerebrospinal fluid.
本实验室首次在小鼠中报道的蛋白质通过哺乳动物血脑屏障进行吸附转胞吞作用的形态学证据,已在静脉注射或向大脑侧脑室/蛛网膜下腔注射与辣根过氧化物酶(HRP)偶联的外源凝集素麦胚凝集素(WGA)的大鼠中得到证实和扩展。血源性WGA-HRP通过吸附性内吞作用迅速进入脑内皮细胞,并标记整个中枢神经系统的血管树。注射后3小时及更长时间,WGA-HRP占据血管周围间隙并标记血管周围细胞和基膜;这种凝集素偶联物从血液到脑的疑似跨内皮转移涉及细胞器内皮内膜系统的特定成分(如质膜、囊泡、内体、高尔基体复合体)。6小时内,反应产物在血管周围基膜以外的细胞外间隙中可见,并标记细胞内的内吞囊泡、内体和致密体以及神经毡的突起。将血脑屏障内皮细胞的无腔表面暴露于注入脑室或蛛网膜下腔的WGA-HRP 1-18小时,表明血脑屏障内皮细胞在无腔表面不进行可证明的吸附性内吞作用。在这种制剂中,没有与隔离血源性WGA-HRP的细胞器类似的内皮细胞器被凝集素偶联物标记;因此,WGA-HRP通过脑内皮细胞从脑到血的显著吸附转胞吞作用不太可能。血脑屏障内皮细胞腔面膜与无腔面膜内化的明显差异表明,血脑屏障在WGA-HRP的吸附性内吞作用方面是极化的。如果确实发生大分子通过血脑屏障的吸附转胞吞作用,该过程似乎是单向的,从血液到脑而不是从脑到血。在从血液到脑的血脑屏障转胞吞作用方案中,无腔面未出现可证明的内吞作用是一个谜,因为胞吐作用和内吞作用是细胞分泌过程中的互补事件。这种与无腔质膜相关的非常规膜行为表明,血源性蛋白质不太可能通过血脑屏障内皮细胞进行显著的转胞吞作用。大分子通过脉络丛上皮细胞的血脑脊液屏障进行转胞吞作用的可能性不像通过血脑屏障内皮细胞那样成问题;提供了额外的证据表明脉络丛上皮细胞在周围参与吸附性内吞作用,并在血液和脑脊液之间双向进行WGA-HRP的吸附转胞吞作用。